Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(R)-Lactate, also known as D-(-)-Lactic acid, is a chiral organic compound that plays a significant role in various industries due to its unique properties. It is a crucial biochemical for proteomics research and is widely utilized in the production of chiral drugs and chemical synthesis.

10326-41-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 10326-41-7 Structure
  • Basic information

    1. Product Name: (R)-Lactate
    2. Synonyms: (r)-lactate;(R)-2-HYDROXYPROPIONIC ACID;D-MILK ACID;D(-)LACTIC ACID;D-LACTIC ACID;D-2-HYDROXYPROPANOIC ACID;(R)-lactic acid;(R)-2-Hydroxypropanoic acid
    3. CAS NO:10326-41-7
    4. Molecular Formula: C3H6O3
    5. Molecular Weight: 90.08
    6. EINECS: 233-713-2
    7. Product Categories: N/A
    8. Mol File: 10326-41-7.mol
  • Chemical Properties

    1. Melting Point: 52.8°
    2. Boiling Point: 227.6 °C at 760 mmHg
    3. Flash Point: 109.9 °C
    4. Appearance: White to Off-white/Low Melting Solid
    5. Density: 1.276 g/cm3
    6. Vapor Pressure: 0.015mmHg at 25°C
    7. Refractive Index: 1.4280 to 1.4320
    8. Storage Temp.: 2-8°C
    9. Solubility: H2O: 0.1 g/mL, clear, colorless
    10. PKA: pK = 3.83(at 25℃)
    11. Water Solubility: Soluble in water (50mg/ml)
    12. Stability: Hygroscopic
    13. Merck: 14,5335
    14. BRN: 1720252
    15. CAS DataBase Reference: (R)-Lactate(CAS DataBase Reference)
    16. NIST Chemistry Reference: (R)-Lactate(10326-41-7)
    17. EPA Substance Registry System: (R)-Lactate(10326-41-7)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 38-41
    3. Safety Statements: 26-39
    4. RIDADR: UN 3265 8/PG III
    5. WGK Germany: 3
    6. RTECS:
    7. F: 3-10
    8. TSCA: Yes
    9. HazardClass: 8
    10. PackingGroup: III
    11. Hazardous Substances Data: 10326-41-7(Hazardous Substances Data)

10326-41-7 Usage

Uses

Used in Proteomics Research:
(R)-Lactate is used as a biochemical for proteomics research, aiding in the study of proteins and their interactions within biological systems.
Used in Pharmaceutical Industry:
(R)-Lactate is used as a building block in the production of chiral drugs, which are essential for the development of new medications with improved efficacy and reduced side effects.
Used in Chemical Synthesis:
(R)-Lactate is used as a reagent in organic synthesis, particularly in the manufacture of adhesives, due to its unique chemical properties.
Used in Leather, Textile, and Tanning Industries:
(R)-Lactate is used as a plasticizer, a catalyst, or an acidifying agent in the leather, textile, and tanning industries, enhancing the quality and performance of the final products.
Used in Tobacco Products:
(R)-Lactate is used as a flavoring agent in the manufacture of tobacco products, contributing to the overall taste and experience of the consumer.

Flammability and Explosibility

Notclassified

Biochem/physiol Actions

In animals, lactic acid is a metabolic compound produced by proliferating cells and during anaerobic conditions such as strenuous exercise. Lactic acid can be oxidized back to pyruvate or converted to glucose via gluconeogenesis. Lactic acid is preferentially metabolized by neurons in several mammal species and during early brain development. D-lactate was utilized four times more slowly than L-lactate, but both isomers are absorbed at the same rate from the intestine.

Check Digit Verification of cas no

The CAS Registry Mumber 10326-41-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,3,2 and 6 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 10326-41:
(7*1)+(6*0)+(5*3)+(4*2)+(3*6)+(2*4)+(1*1)=57
57 % 10 = 7
So 10326-41-7 is a valid CAS Registry Number.
InChI:InChI=1/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m0/s1

10326-41-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (L0266)  D-Lactic Acid  >90.0%(T)

  • 10326-41-7

  • 5g

  • 950.00CNY

  • Detail
  • TCI America

  • (L0266)  D-Lactic Acid  >90.0%(T)

  • 10326-41-7

  • 25g

  • 3,320.00CNY

  • Detail

10326-41-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name (R)-lactic acid

1.2 Other means of identification

Product number -
Other names D-lactate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10326-41-7 SDS

10326-41-7Synthetic route

2-oxo-propionic acid
127-17-3

2-oxo-propionic acid

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
With phosphonic Acid; lactate dehydrogenase V152R mutant; phosphorous dehydrogenase I151R mutant; NAD In aq. buffer at 30℃; for 12h; pH=7.5; Reagent/catalyst; Time; Enzymatic reaction;100%
With phosphate buffer; ADH (EC 1.1.1.2); MV2+; nicotinamide adenine dinucleotide phosphate In water; tert-butyl alcohol for 30h; electrolysis' other reaction system;8.3E-6 mol
With Leuconostoc lactis ketoacid reductase; NADH In aq. phosphate buffer at 35℃; for 10h; pH=7; Enzymatic reaction; enantioselective reaction;65.2 %Chromat.
(2R)-propane-1,2-diol
4254-14-2

(2R)-propane-1,2-diol

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
Stage #1: (2R)-propane-1,2-diol With Rh(OTf)(trop2NH)(PPh3); water; cyclohexanone; sodium hydroxide at 20℃; for 5h; Inert atmosphere;
Stage #2: With hydrogenchloride In water Inert atmosphere; chemoselective reaction;
91%
1-dodecyl L-lactate
232944-80-8

1-dodecyl L-lactate

A

D-Lactic acid
10326-41-7

D-Lactic acid

B

1-dodecyl alcohol
112-53-8

1-dodecyl alcohol

Conditions
ConditionsYield
With 2C33H37N*H2O7S2; water at 80℃; for 4h;A 80%
B 87%
methyl lactate
547-64-8

methyl lactate

A

D-Lactic acid
10326-41-7

D-Lactic acid

B

(S)-Methyl lactate
27871-49-4

(S)-Methyl lactate

Conditions
ConditionsYield
With Dactylosporangium aurantiacum esterase WDEst9 In aq. buffer at 30℃; for 3h; pH=8.5; Catalytic behavior; Concentration; pH-value; Reagent/catalyst; Solvent; Temperature; Time; Green chemistry; Enzymatic reaction; enantioselective reaction;A n/a
B 86.7%
D-Alanine
338-69-2

D-Alanine

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
With sulfuric acid; sodium nitrite82%
With trifluoroacetic acid; sodium nitrite In water at 20℃; for 6h;62%
With sulfuric acid; sodium nitrite In water at 0℃; for 2h;
Isobutyl (R)-lactate
61597-96-4

Isobutyl (R)-lactate

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
With lithium hydroxide monohydrate In tetrahydrofuran; water at 0 - 20℃; for 48h; Inert atmosphere;77%
D-Alanine
338-69-2

D-Alanine

A

D-Lactic acid
10326-41-7

D-Lactic acid

B

D-lactide
4511-42-6

D-lactide

Conditions
ConditionsYield
With sulfuric acid; sodium nitrite In water at 0 - 20℃; stereoselective reaction;A 58%
B < 3 %Spectr.
propylene glycol
57-55-6

propylene glycol

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
With phosphate buffer; Gluconobacter oxydans DSM 2003 cells at 28℃; for 20h; pH=6.0;48%
ethyl 2-hydroxypropionate
97-64-3, 2676-33-7

ethyl 2-hydroxypropionate

A

L-Lactic acid
79-33-4

L-Lactic acid

B

D-Lactic acid
10326-41-7

D-Lactic acid

C

(R)-Ethyl lactate
7699-00-5

(R)-Ethyl lactate

Conditions
ConditionsYield
With ammonium hydroxide at 30℃; pH=6.9;A n/a
B n/a
C 34.5%
citric acid
77-92-9

citric acid

A

Oxalacetic acid
328-42-7

Oxalacetic acid

B

L-Lactic acid
79-33-4

L-Lactic acid

C

D-Lactic acid
10326-41-7

D-Lactic acid

D

3-hydroxy-2-butanon
513-86-0, 52217-02-4

3-hydroxy-2-butanon

E

acetic acid
64-19-7

acetic acid

F

2-oxo-propionic acid
127-17-3

2-oxo-propionic acid

Conditions
ConditionsYield
With Leuconostoc mesenteroides at 30℃; for 1h; potassium phosphate buffer, pH 5.0; other conditions also investigated; several substrates investigated;A 0.66%
B 0.06%
C 1.77%
D 6.86%
E 15.5%
F 0.05%
citric acid
77-92-9

citric acid

A

Oxalacetic acid
328-42-7

Oxalacetic acid

B

L-Lactic acid
79-33-4

L-Lactic acid

C

D-Lactic acid
10326-41-7

D-Lactic acid

D

acetic acid
64-19-7

acetic acid

E

2-oxo-propionic acid
127-17-3

2-oxo-propionic acid

F

dimethylglyoxal
431-03-8

dimethylglyoxal

Conditions
ConditionsYield
With Leuconostoc mesenteroides at 30℃; for 1h; potassium phosphate buffer, pH 5.0; other conditions also investigated; several substrates investigated;A 0.66%
B 0.06%
C 1.77%
D 15.5%
E 0.05%
F 1.72%
LACTIC ACID
849585-22-4

LACTIC ACID

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
mit Hilfe von Chinin;
mit Hilfe von Morphin;
With MORPHIN
mit Hilfe von Strychnin;
D-Fructose
57-48-7

D-Fructose

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
bei der Vergaerung durch Bacterium coli communis (zu mehr als 75prozent aus l-Milchsaeure besteht);
bei der Vergaerung durch Lactobacillus Leichmanni;
pyruvic acid menthyl ester
53651-68-6

pyruvic acid menthyl ester

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
With aluminium amalgam und Verseifung der Produkte mit alkoholischem Kaliumhydroxyd;
(R)-2-chloropropionic acid
7474-05-7

(R)-2-chloropropionic acid

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
With water; silver(l) oxide
(S)-2-bromopropanoic acid
32644-15-8

(S)-2-bromopropanoic acid

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
With potassium hydroxide
R-(+)-2-bromopropionic acid
10009-70-8

R-(+)-2-bromopropionic acid

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
With water; silver carbonate
(S)-2-iodo-propionic acid
18791-44-1

(S)-2-iodo-propionic acid

furan-2,3,5(4H)-trione pyridine (1:1)

furan-2,3,5(4H)-trione pyridine (1:1)

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
Hydrolysis;
(S)-2-iodo-propionic acid
18791-44-1

(S)-2-iodo-propionic acid

A

LACTIC ACID
849585-22-4

LACTIC ACID

B

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
With sodium hydroxide Hydrolysis;
mannitol
69-65-8

mannitol

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
bei der Vergaerung durch eine auf Birnen gefundene Mikrobe;
bei der Vergaerung durch Bacterium formicicum;
durch Vergaerung mit Pneumokokkus(Friedlaender);
mannitol
69-65-8

mannitol

A

ethanol
64-17-5

ethanol

B

D-Lactic acid
10326-41-7

D-Lactic acid

C

acetic acid
64-19-7

acetic acid

D

butan-1-ol
71-36-3

butan-1-ol

Conditions
ConditionsYield
bei der Vergaerung durch Clostridium thermocellum;Produkt 5:Buttersaeure;
D-sorbitol
50-70-4

D-sorbitol

A

D-Fructose
57-48-7

D-Fructose

B

D-Lactic acid
10326-41-7

D-Lactic acid

C

D-glucose
50-99-7

D-glucose

Conditions
ConditionsYield
beim Durchleiten von sorbithaltigem Rinderblut durch isolierte Hundeleber;
L-arabinose
5328-37-0

L-arabinose

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
durch Vergaerung mit Pneumokokkus(Friedlaender);
2-amino-2-deoxyglucose
3416-24-8

2-amino-2-deoxyglucose

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
bei der Einw. von Bac. subtilis und Bac. prodigiosus;
D-glucose
50-99-7

D-glucose

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
bei der Gaerung der alkalischen Loesungen durch den Bacillus acidi laevolactici;
at 36℃; bei der Gaerung der alkalischen Loesungen durch den Bacillus acidi laevolactici;
bei der Vergaerung durch eine auf Birnen gefundene Mikrobe;
D-Galactose
59-23-4

D-Galactose

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
durch Vergaerung mit Pneumokokkus(Friedlaender);
bei der Vergaerung durch Lactobacillus Leichmanni;
Conditions
ConditionsYield
bei der Gaerung der alkalischen Loesungen durch den Typhusbazillus;
durch Vergaerung mit Pneumokokkus(Friedlaender);
durch den Pilz Rhizopus chinensis;
beim Vergaeren durch Betacoccus arabinosaceus;
Vergaerung durch Lactobacillus leichmannii sowie Reinigung ueber das Zinksalz und durch folgende Einw. eines Ionenaustausch-Harzes;
D-glucosaminic acid
3646-68-2

D-glucosaminic acid

A

D-Lactic acid
10326-41-7

D-Lactic acid

B

succinic acid
110-15-6

succinic acid

Conditions
ConditionsYield
durch Escherishia Coli;
D-glucosaminic acid
3646-68-2

D-glucosaminic acid

A

D-Lactic acid
10326-41-7

D-Lactic acid

B

oxalic acid
144-62-7

oxalic acid

C

acetic acid
64-19-7

acetic acid

Conditions
ConditionsYield
nach Verabreichung an Hunde und Kaninchen im Harn ausscheiden;
fructose-1,6-bisphosphate
488-69-7

fructose-1,6-bisphosphate

D-Lactic acid
10326-41-7

D-Lactic acid

Conditions
ConditionsYield
With GLUTATHIONE; toluene bei der Vergaerung durch Hefe;
With GLUTATHIONE; toluene bei der Vergaerung durch Hefe; in diesen Gaerensaetzen entsteht vielleicht intermediaer Methylglyoxal durch einen nichtfermentativen Prozess;
D-Lactic acid
10326-41-7

D-Lactic acid

2-oxo-propionic acid
127-17-3

2-oxo-propionic acid

Conditions
ConditionsYield
With oxygen at 100℃; under 75.0075 Torr; for 8h; Temperature; Pressure; Autoclave;94.3%
With mutant 3-isopropylmalate dehydrogenase(Gly89-Gly-Leu90); nicotinamide adenine dinucleotide In water at 60℃; for 2h; pH=7.8; Enzyme kinetics;
With nicotinamide flucytosine dinucleotide at 25℃; pH=7.5; aq. buffer; Enzymatic reaction;
With D-lactate dehydrogenase of Planctomyces brasiliensis at 25℃; for 1h; pH=7; Concentration; pH-value; Reagent/catalyst; Temperature; Enzymatic reaction;
With D-lactate oxidase from Saccharomyces cerevisiae; oxygen; catalase In aq. buffer at 30℃; pH=7.4; Reagent/catalyst; Enzymatic reaction;
D-Lactic acid
10326-41-7

D-Lactic acid

didecyldimethylammonium chloride
7173-51-5

didecyldimethylammonium chloride

didecyldimethylammonium L-lactate
1308889-80-6

didecyldimethylammonium L-lactate

Conditions
ConditionsYield
Stage #1: D-Lactic acid With potassium hydroxide In water Reflux;
Stage #2: didecyldimethylammonium chloride In water at 20℃; for 5h;
94%
D-Lactic acid
10326-41-7

D-Lactic acid

((S)-1-Phenyl-ethyl)-{4-[6-piperidin-4-yl-3-(3-trifluoromethyl-phenyl)-pyridazin-4-yl]-pyrimidin-2-yl}-amine
271247-18-8

((S)-1-Phenyl-ethyl)-{4-[6-piperidin-4-yl-3-(3-trifluoromethyl-phenyl)-pyridazin-4-yl]-pyrimidin-2-yl}-amine

(R)-2-Hydroxy-1-{4-[5-[2-((S)-1-phenyl-ethylamino)-pyrimidin-4-yl]-6-(3-trifluoromethyl-phenyl)-pyridazin-3-yl]-piperidin-1-yl}-propan-1-one

(R)-2-Hydroxy-1-{4-[5-[2-((S)-1-phenyl-ethylamino)-pyrimidin-4-yl]-6-(3-trifluoromethyl-phenyl)-pyridazin-3-yl]-piperidin-1-yl}-propan-1-one

Conditions
ConditionsYield
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide93%
D-Lactic acid
10326-41-7

D-Lactic acid

9-anthryldiazomethane
10401-59-9

9-anthryldiazomethane

(R)-2-Hydroxy-propionic acid anthracen-9-ylmethyl ester

(R)-2-Hydroxy-propionic acid anthracen-9-ylmethyl ester

Conditions
ConditionsYield
In diethyl ether for 0.5h; Ambient temperature;90%
In diethyl ether for 0.5h; Ambient temperature;
In methanol at 20℃; for 0.5h;
D-Lactic acid
10326-41-7

D-Lactic acid

benzyl alcohol
100-51-6

benzyl alcohol

Conditions
ConditionsYield
Stage #1: benzyl alcohol With toluene-4-sulfonic acid In benzene for 0.5h; Reflux;
Stage #2: D-Lactic acid In benzene Reflux;
88%
With salicylaldehyde In toluene at 100℃; for 18h; Inert atmosphere; chemoselective reaction;85%
With hydrogenchloride for 18h;51.3%
D-Lactic acid
10326-41-7

D-Lactic acid

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

(2S)-2-<(tert-Butyldimethylsilyl)oxy>lactic acid
129919-88-6

(2S)-2-<(tert-Butyldimethylsilyl)oxy>lactic acid

Conditions
ConditionsYield
With dmap; triethylamine87%
ethanol
64-17-5

ethanol

D-Lactic acid
10326-41-7

D-Lactic acid

(R)-Ethyl lactate
7699-00-5

(R)-Ethyl lactate

Conditions
ConditionsYield
With salicylaldehyde at 80℃; for 28h; Inert atmosphere; chemoselective reaction;85%
With sulfuric acid at 120℃; for 8h; Molecular sieve;25%
With hydrogenchloride
With sulfuric acid; benzene durch azeotrope Destillation;
D-Lactic acid
10326-41-7

D-Lactic acid

9-(6-methoxypyridin-3-yl)-3-methyl-1-(piperidin-4-yl)-3,4-dihydropyrimido[5,4-c][1,5]naphthyridin-2(1H)-one hydrochloride salt

9-(6-methoxypyridin-3-yl)-3-methyl-1-(piperidin-4-yl)-3,4-dihydropyrimido[5,4-c][1,5]naphthyridin-2(1H)-one hydrochloride salt

(R)-1-[1-(2-hydroxypropionyl)piperidine-4-yl]-9-(6-methoxypyridin-3-yl)-3-methyl-3,4-dihydropyrimido[5,4-c][1,5]naphthyridin-2(1H)-one

(R)-1-[1-(2-hydroxypropionyl)piperidine-4-yl]-9-(6-methoxypyridin-3-yl)-3-methyl-3,4-dihydropyrimido[5,4-c][1,5]naphthyridin-2(1H)-one

Conditions
ConditionsYield
Stage #1: 9-(6-methoxypyridin-3-yl)-3-methyl-1-(piperidin-4-yl)-3,4-dihydropyrimido[5,4-c][1,5]naphthyridin-2(1H)-one hydrochloride salt With triethylamine In dichloromethane at 20℃; for 0.5h;
Stage #2: D-Lactic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 2h;
81.4%
Stage #1: 9-(6-methoxypyridin-3-yl)-3-methyl-1-(piperidin-4-yl)-3,4-dihydropyrimido[5,4-c][1,5]naphthyridin-2(1H)-one hydrochloride salt With triethylamine In dichloromethane at 20℃; for 0.5h;
Stage #2: D-Lactic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 2h;
88mg
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane; water at 20℃; for 2h;88 mg
D-Lactic acid
10326-41-7

D-Lactic acid

methyl 4-({4-[3-cyano-4-(piperidin-4-yloxy)phenyl]pyrimidin-2-yl}amino)benzoate
1292317-84-0

methyl 4-({4-[3-cyano-4-(piperidin-4-yloxy)phenyl]pyrimidin-2-yl}amino)benzoate

trifluoroacetic acid
76-05-1

trifluoroacetic acid

methyl 4-({4-[3-cyano-4-({1-[(2R)-2-hydroxypropanoyl]piperidin-4-yl}oxy)phenyl]pyrimidin-2-yl}amino)benzoate trifluoroacetate

methyl 4-({4-[3-cyano-4-({1-[(2R)-2-hydroxypropanoyl]piperidin-4-yl}oxy)phenyl]pyrimidin-2-yl}amino)benzoate trifluoroacetate

Conditions
ConditionsYield
Stage #1: D-Lactic acid; methyl 4-({4-[3-cyano-4-(piperidin-4-yloxy)phenyl]pyrimidin-2-yl}amino)benzoate With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide for 16h;
Stage #2: trifluoroacetic acid In water; acetonitrile
81%
1,10-Phenanthroline
66-71-7

1,10-Phenanthroline

malachite

malachite

D-Lactic acid
10326-41-7

D-Lactic acid

[copper(II)-di(lactato)-(1,10-phenanthroline)]*4H2O

[copper(II)-di(lactato)-(1,10-phenanthroline)]*4H2O

Conditions
ConditionsYield
In ethanol suspn. of Cu compd. and lactic acid in EtOH refluxed for 4 h at 75°C, 1,10-phenanthroline added, refluxed for 2 h, then stirred for several d; filtered, washed with EtOH, dried over CaCl2; elem. anal.;80%
D-Lactic acid
10326-41-7

D-Lactic acid

vanadia

vanadia

bis(triphenylphosphine)iminium chloride
21050-13-5

bis(triphenylphosphine)iminium chloride

[VO2(lac)]2(Ph3P=NPPh3)2

[VO2(lac)]2(Ph3P=NPPh3)2

Conditions
ConditionsYield
With tetraethylammonium hydroxide In water; acetonitrile V2O5 was added to aq. soln. Et4NOH and warmed to 60°C, soln. was filtered, lactic acid was added with stirring, pH was raised from 3.0 to6.3 by Et4NOH, soln. was concd. in air stream, soln. PPNCl in MeCN was added and left overnight; product was filtered, washed with MeCN, and dried in vacuo; elem. anal.;78%
D-Lactic acid
10326-41-7

D-Lactic acid

(rac)-4-bromo-5,6,7,8-tetrahydroisoquinolin-8-amine
1428651-87-9

(rac)-4-bromo-5,6,7,8-tetrahydroisoquinolin-8-amine

(R)-N-((R,S)-4-bromo-5,6,7,8-tetrahydro-isoquinolin-8-yl)-2-hydroxy-propionamide
1469979-88-1

(R)-N-((R,S)-4-bromo-5,6,7,8-tetrahydro-isoquinolin-8-yl)-2-hydroxy-propionamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; Inert atmosphere;77%
D-Lactic acid
10326-41-7

D-Lactic acid

5-{9-(cyclopropylmethyl)-8-[(3R)-3-methylpiperazin-1-yl]-6-morpholin-4-yl-9H-purin-2-yl}pyrimidin-2-amine
1222104-79-1

5-{9-(cyclopropylmethyl)-8-[(3R)-3-methylpiperazin-1-yl]-6-morpholin-4-yl-9H-purin-2-yl}pyrimidin-2-amine

(2R)-1-{(2R)-4-[2-(2-Aminopyrimidin-5-yl)-9-(cyclopropylmethyl)-6-morpholin-4-yl-9H-purin-8-yl]-2-methylpiperazin-1-yl}-1-oxopropan-2-ol
1222104-99-5

(2R)-1-{(2R)-4-[2-(2-Aminopyrimidin-5-yl)-9-(cyclopropylmethyl)-6-morpholin-4-yl-9H-purin-8-yl]-2-methylpiperazin-1-yl}-1-oxopropan-2-ol

Conditions
ConditionsYield
With benzotriazol-1-ol; triethylamine; dicyclohexyl-carbodiimide In dichloromethane; N,N-dimethyl-formamide at 20 - 40℃; for 40.5h;76%
D-Lactic acid
10326-41-7

D-Lactic acid

benzyl bromide
100-39-0

benzyl bromide

Conditions
ConditionsYield
Stage #1: D-Lactic acid With caesium carbonate In methanol; water pH=7;
Stage #2: benzyl bromide In methanol; water; N,N-dimethyl-formamide at 20℃; for 6h;
75%
With sodium hydrogencarbonate In N,N-dimethyl-formamide at 80 - 100℃; for 1h;68%
With potassium carbonate In N,N-dimethyl-formamide for 14h; Ambient temperature;
In N,N-dimethyl-formamide at 50℃; for 6h; Inert atmosphere; Glovebox; Sealed tube;
D-Lactic acid
10326-41-7

D-Lactic acid

(rac)-6-(8-amino-5,6,7,8-tetrahydroisoquinolin-4-yl)-1-methyl-3,4-dihydroquinolin-2(1H)-one
1428651-83-5

(rac)-6-(8-amino-5,6,7,8-tetrahydroisoquinolin-4-yl)-1-methyl-3,4-dihydroquinolin-2(1H)-one

(2R)-2-hydroxy-N-[(4R,S)-4-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl]propanamide
1428652-31-6

(2R)-2-hydroxy-N-[(4R,S)-4-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl]propanamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; diisopropylamine In dichloromethane at 0 - 20℃; Inert atmosphere;75%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃; Inert atmosphere;75%
D-Lactic acid
10326-41-7

D-Lactic acid

3-(((1R,2R)-2-((4-(6-fluorobenzo[d]isoxazole-3-yl)piperidin-1-yl)methyl)cyclohexyl)methyl)oxazolidine-2-one

3-(((1R,2R)-2-((4-(6-fluorobenzo[d]isoxazole-3-yl)piperidin-1-yl)methyl)cyclohexyl)methyl)oxazolidine-2-one

3-(((1R,2R)-2-((4-(6-fluorobenzo[d]isoxazole-3-yl)piperidin-1-yl)methyl)cyclohexyl)methyl)oxazolidine-2-one lactic acid salt

3-(((1R,2R)-2-((4-(6-fluorobenzo[d]isoxazole-3-yl)piperidin-1-yl)methyl)cyclohexyl)methyl)oxazolidine-2-one lactic acid salt

Conditions
ConditionsYield
In ethanol Reflux;74.1%
D-Lactic acid
10326-41-7

D-Lactic acid

(R)-3-iodo-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(R)-3-iodo-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

(R)-1-((R)-3-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2-hydroxypropan-1-one

(R)-1-((R)-3-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2-hydroxypropan-1-one

Conditions
ConditionsYield
Stage #1: D-Lactic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In N,N-dimethyl-formamide at 20℃; for 0.5h;
Stage #2: (R)-3-iodo-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine In N,N-dimethyl-formamide at 20℃; for 5h;
73.3%
D-Lactic acid
10326-41-7

D-Lactic acid

5-(9-isobutyl-6-morpholin-4-yl-8-piperazin-1-yl-9H-purin-2-yl)pyrimidin-2-amine
1222105-31-8

5-(9-isobutyl-6-morpholin-4-yl-8-piperazin-1-yl-9H-purin-2-yl)pyrimidin-2-amine

(2R)-1-{4-[2-(2-Aminopyrimidin-5-yl)-9-isobutyl-6-morpholin-4-yl-9H-purin-8-yl]piperazin-1-yl}-1-oxopropan-2-ol
1222104-78-0

(2R)-1-{4-[2-(2-Aminopyrimidin-5-yl)-9-isobutyl-6-morpholin-4-yl-9H-purin-8-yl]piperazin-1-yl}-1-oxopropan-2-ol

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In N,N-dimethyl-formamide at 20℃; for 96h;73%
D-Lactic acid
10326-41-7

D-Lactic acid

5-bromo-3-fluoro-N1-(propan-2-yl)benzene-1,2-diamine

5-bromo-3-fluoro-N1-(propan-2-yl)benzene-1,2-diamine

(1R)-1-[6-bromo-4-fluoro-1-(propan-2-yl)-1H-benzimidazol-2-yl]ethan-1-ol

(1R)-1-[6-bromo-4-fluoro-1-(propan-2-yl)-1H-benzimidazol-2-yl]ethan-1-ol

Conditions
ConditionsYield
for 44h; Time; Heating;71%
D-Lactic acid
10326-41-7

D-Lactic acid

5-amino-N-(4-(azepan-4-yloxy)pyrimidin-5-yl)-2-(2,6-difluorophenyl)thiazole-4-carboxamide
1422470-13-0

5-amino-N-(4-(azepan-4-yloxy)pyrimidin-5-yl)-2-(2,6-difluorophenyl)thiazole-4-carboxamide

C20H20F2N6O2S*C3H6O3

C20H20F2N6O2S*C3H6O3

Conditions
ConditionsYield
In methanol; dichloromethane at 20 - 30℃; for 0.5h;67.8%
D-Lactic acid
10326-41-7

D-Lactic acid

bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

L-lactic acid O-carboxyanhydride
91049-50-2

L-lactic acid O-carboxyanhydride

Conditions
ConditionsYield
With pyrographite In tetrahydrofuran at 0 - 20℃; for 8h;65%
D-Lactic acid
10326-41-7

D-Lactic acid

5-chloro-N-[3,5-dimethyl-1-(4-piperidinyl)-1H-pyrazol-4-yl]-4-(pyrazolo[1,5-a]pyridin-3-yl)-2-pyrimidinamine

5-chloro-N-[3,5-dimethyl-1-(4-piperidinyl)-1H-pyrazol-4-yl]-4-(pyrazolo[1,5-a]pyridin-3-yl)-2-pyrimidinamine

(2R)-1-[4-(4-{[5-chloro-4-(pyrazolo[1,5-a]pyridin-3-yl)-2-pyrimidinyl]amino}-3,5-dimethyl-1H-pyrazol-1-yl)-1-piperidinyl]-2-hydroxy-1-propanone

(2R)-1-[4-(4-{[5-chloro-4-(pyrazolo[1,5-a]pyridin-3-yl)-2-pyrimidinyl]amino}-3,5-dimethyl-1H-pyrazol-1-yl)-1-piperidinyl]-2-hydroxy-1-propanone

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; for 2h; Inert atmosphere;64%
D-Lactic acid
10326-41-7

D-Lactic acid

3-methyl-8-(6-(1-methyl-1H-pyrazol-4-yl)pyridin-(4-piperidin-3-yl)phenyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one hydrochloride

3-methyl-8-(6-(1-methyl-1H-pyrazol-4-yl)pyridin-(4-piperidin-3-yl)phenyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one hydrochloride

1-(4-(1-((R)-2-hydroxypropionyl)piperidin-3-yl)phenyl)3-methyl-8-(6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-1H-imidazo[4,5-c]quinolin-2-(3H)-one

1-(4-(1-((R)-2-hydroxypropionyl)piperidin-3-yl)phenyl)3-methyl-8-(6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-1H-imidazo[4,5-c]quinolin-2-(3H)-one

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃;63.4%
D-Lactic acid
10326-41-7

D-Lactic acid

tert-butyl 4-[(6-aminothieno[3,2-b]pyridin-7-yl)amino]-3-fluoropiperidine-1-carboxylate
1607590-13-5

tert-butyl 4-[(6-aminothieno[3,2-b]pyridin-7-yl)amino]-3-fluoropiperidine-1-carboxylate

tert-butyl 3-fluoro-4-[(6-{[(2R)-2-hydroxypropanoyl]amino}thieno[3,2-b]pyridin-7-yl)amino]piperidine-1-carboxylate
1607590-14-6

tert-butyl 3-fluoro-4-[(6-{[(2R)-2-hydroxypropanoyl]amino}thieno[3,2-b]pyridin-7-yl)amino]piperidine-1-carboxylate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 20℃;62%

10326-41-7Relevant articles and documents

Bridging racemic lactate esters with stereoselective polylactic acid using commercial lipase catalysis

Van Wouwe, Pieter,Dusselier, Michiel,Basic, Aurelie,Sels, Bert F.

, p. 2817 - 2824 (2013)

A productive and enantioselective hydrolysis of racemic mixtures of lactate esters with commercial Candida rugosa lipase was performed. This step contributes to a novel envisioned route for stereoselective PLA production by combining recent chemocatalytic developments with this biocatalytic contribution, foreseeing two separate l- and d-lactate enantiomer streams. A study of the hydrolysis kinetics identified an unexpected rate determining step at the origin of an unprecedented ester reactivity order.

Synthesis of (R)-lactic acid and (2R,5R)-2-tert-Butyl-5-methyl-1,3-dioxolan-4-one

Aitken, R. Alan,Meehan, Anna,Power, Lynn A.

, p. 1557 - 1559 (2015)

Abstract A convenient procedure for the synthesis of very expensive (R)-lactic acid from relatively inexpensive (R)-alanine is described. Its subsequent conversion into a chiral dioxolanone can be carried out by using an inexpensive pivalaldehyde-tert-butanol mixture.

Structures, chemotaxonomic significance, cytotoxic and Na+,K+-ATPase inhibitory activities of new cardenolides from Asclepias curassavica

Zhang, Rong-Rong,Tian, Hai-Yan,Tan, Ya-Fang,Chung, Tse-Yu,Sun, Xiao-Hui,Xia, Xue,Ye, Wen-Cai,Middleton, David A.,Fedosova, Natalya,Esmann, Mikael,Tzen, Jason T. C.,Jiang, Ren-Wang

, p. 8919 - 8929 (2014)

Five new cardenolide lactates (1-5) and one new dioxane double linked cardenolide glycoside (17) along with 15 known compounds (6-16 and 18-21) were isolated from the ornamental milkweed Asclepias curassavica. Their structures were elucidated by extensive spectroscopic methods (IR, UV, MS, 1D- and 2D-NMR). The molecular structures and absolute configurations of 1-3 and 17 were further confirmed by single-crystal X-ray diffraction analysis. Simultaneous isolation of dioxane double linked cardenolide glycosides (17-21) and cardenolide lactates (1-5) provided unique chemotaxonomic markers for this genus. Compounds 1-21 were evaluated for the inhibitory activities against DU145 prostate cancer cells. The dioxane double linked cardenolide glycosides showed the most potent cytotoxic effect followed by normal cardenolides and cardenolide lactates, while the C21 steroids were non-cytotoxic. Enzymatic assay established a correlation between the cytotoxic effects in DU145 cancer cells and the Ki for the inhibition of Na+,K+-ATPase. Molecular docking analysis revealed relatively strong H-bond interactions between the bottom of the binding cavity and compounds 18 or 20, and explained why the dioxane double linked cardenolide glycosides possessed higher inhibitory potency on Na+,K+-ATPase than the cardenolide lactate. This journal is

Enhancement of the catalytic activity of D-lactate dehydrogenase from Sporolactobacillus laevolacticus by site-directed mutagenesis

Nakano, Kento,Sawada, Shoichi,Yamada, Ryosuke,Mimitsuka, Takashi,Ogino, Hiroyasu

, p. 214 - 218 (2018)

Sporolactobacillus laevolacticus is a producer of D-lactic acid with high optical purity. The amino acid sequence of D-lactate dehydrogenase (D-LDH) from S. laevolacticus was compared with those of other lactate producers. To enhance the activity of D-LDH from S. laevolacticus, some amino acid residues close to the substrate binding site or the active center were replaced by site-directed mutagenesis. Ala234 of D-LDH from S. laevolacticus was found to be an important amino acid residue that positively affects catalytic activity. Site-saturation mutagenesis of the 234th residue was performed. The mutant D-LDH at the 234th residue from alanine to serine or glycine showed enhanced catalytic activity toward pyruvate. The kinetic analysis revealed that the kcat/Km of D-LDH_A234S and _A234G on pyruvate increased 1.9- and 1.2-fold, respectively. Furthermore, the double mutant D-LDH_T75L/A234S improved kcat/Km by 6.8-fold compared to that of wild-type D-LDH. These results showed the potential of the mutant D-LDH for microbial production of D-lactic acid by heterologous expression.

Use of wastewater sludge as a raw material for production of L-lactic acid

Nakasaki, Kiyohiko,Akakura, Naoki,Adachi, Tomohiko,Akiyama, Tetsuo

, p. 198 - 200 (1999)

This study utilizes wastewater sludges to produce L-lactic acid, a precursor of biodegradable plastic. The high concentrations of cellulose contained in the sludge, derived from a paper manufacturing facility, have been found to be convertible to L-lactic acid at a rate as high as 6.91 g/L. To achieve such a high conversion rate, the sludge must be pretreated with cellulase. This pretreatment includes inoculation of the sludge with lactic acid bacteria, strain LA1, after the sludge has been subjected to enzymatic hydrolysis. This study utilizes wastewater sludges to produce L-lactic acid, a precursor of biodegradable plastic. The high concentrations of cellulose contained in the sludge, derived from a paper manufacturing facility, have been found to be convertible to L-lactic acid at a rate as high as 6.91 g/L. To achieve such a high conversion rate, the sludge must be pretreated with cellulase. This pretreatment includes inoculation of the sludge with lactic acid bacteria, strain LA1, after the sludge has been subjected to enzymatic hydrolysis.

Reversible ketomethylene-based inhibitors of human neutrophil proteinase 3

Budnjo, Adnan,Narawane, Shailesh,Grauffel, Cédric,Schillinger, Anne-Sophie,Fossen, Torgils,Reuter, Nathalie,Haug, Bengt Erik

, p. 9396 - 9408 (2014)

Neutrophil serine proteases, proteinase 3 (PR3) and human neutrophil elastase (HNE), are considered as targets for chronic inflammatory diseases. Despite sharing high sequence similarity, the two enzymes have different substrate specificities and functions. While a plethora of HNE inhibitors exist, PR3 specific inhibitors are still in their infancy. We have designed ketomethylene-based inhibitors for PR3 that show low micromolar IC50 values. Their synthesis was made possible by amending a previously reported synthesis of ketomethylene dipeptide isosteres to allow for the preparation of derivatives suitable for solid phase peptide synthesis. The best inhibitor (Abz-VADnV[ψ](COCH2)ADYQ-EDDnp) was found to be selective for PR3 over HNE and to display a competitive and reversible inhibition mechanism. Molecular dynamics simulations show that the interactions between enzyme and ketomethylene-containing inhibitors are similar to those with the corresponding substrates. We also confirm that N- and C-terminal FRET groups are important for securing high inhibitory potency toward PR3.

Site-Specific, covalent immobilization of dehalogenase ST2570 catalyzed by formylglycine-generating enzymes and its application in batch and semi-continuous flow reactors

Jian, Hui,Wang, Yingwu,Bai, Yan,Li, Rong,Gao, Renjun

, (2016)

Formylglycine-generating enzymes can selectively recognize and oxidize cysteine residues within the sulfatase sub motif at the terminus of proteins to form aldehyde-bearing formylglycine (FGly) residues, and are normally used in protein labeling. In this study, an aldehyde tag was introduced to proteins using formylglycine-generating enzymes encoded by a reconstructed set of the pET28a plasmid system for enzyme immobilization. The haloacid dehalogenase ST2570 from Sulfolobus tokodaii was used as a model enzyme. The C-terminal aldehyde-tagged ST2570 (ST2570CQ) exhibited significant enzymological properties, such as new free aldehyde groups, a high level of protein expression and improved enzyme activity. SBA-15 has widely been used as an immobilization support for its large surface and excellent thermal and chemical stability. It was functionalized with amino groups by aminopropyltriethoxysilane. The C-terminal aldehyde-tagged ST2570 was immobilized to SBA-15 by covalent binding. The site-specific immobilization of ST2570 avoided the chemical denaturation that occurs in general covalent immobilization and resulted in better fastening compared to physical adsorption. The site-specific immobilized ST2570 showed 3-fold higher thermal stability, 1.2-fold higher catalytic ability and improved operational stability than free ST2570. The site-specific immobilized ST2570 retained 60% of its original activity after seven cycles of batch operation, and it was superior to the ST2570 immobilized to SBA-15 by physical adsorption, which loses 40% of its original activity when used for the second time. It is remarkable that the site-specific immobilized ST2570 still retained 100% of its original activity after 10 cycles of reuse in the semi-continuous flow reactor. Overall, these results provide support for the industrial-scale production and application of site-specific, covalently immobilized ST2570.

Affinity of a vancomycin polymer with bacterial surface models

Arimoto, Hirokazu,Oishi, Takehisa,Nishijima, Manabu,Kinumi, Tomoya

, p. 3347 - 3350 (2001)

The affinity between a vancomycin polymer (3) and cell wall intermediate mimics of vancomycin resistant bacteria (VRE) was determined by use of surface plasmon resonance (SPR). The increased affinity of 3 over monomeric vancomycin derivatives 1 and 2 suggests the importance of tighter binding to VRE surfaces in the enhanced antibacterial activities of 3.

Development of a Novel Biocatalyst for the Resolution of rac-Pantolactone

Kesseler, Maria,Friedrich, Thomas,Hoeffken, Hans Wolfgang,Hauer, Bernhard

, p. 1103 - 1110 (2002)

A novel L-pantolactone hydrolase, Lph, from Agrobacterium tumefaciens Lu681 was characterized, which stereospecifically hydrolyses L-pantolactone to L-pantoic acid yielding D-pantolactone with > 95% enantiomeric excess. The enzyme was found to be a 30 kDa-Zn2+-hydrolase with a Km for L-pantolactone of 7 mM and a Vmax of 30 U/mg. The corresponding lph gene was identified as an 807 bp ORF and cloned into E. coli. It was overexpressed under control of Ptac and Prha yielding enzyme activities of up to 600 U/g dry weight. Resolution of D,L-pantolactone in repeated batches with isolated Lph and enzyme recovery by membrane filtration gave D-pantolactone with 50% yield and 90-95% ee over 6 days. Covalent immobilization to EupergitC led to a stable biocatalyst easy to handle in a repeated batch production of D-pantolactone. Further improvements in the activity of Lph were achieved by directed evolution of the enzyme. Activities of mutants F62S, K197D and F100L were increased 2.3, 1.7, and 1.5 fold, respectively.

D-(-)-Lactic acid production from cellobiose and cellulose by Lactobacillus lactis mutant RM2-24

Singhvi, Mamta,Joshi, Dipti,Adsul, Mukund,Varma, Anjani,Gokhale, Digambar

, p. 1106 - 1109 (2010)

Lactobacillus lactis mutant RM2-24 utilizes cellobiose efficiently, converting it into d-(-)-lactic acid. Cellobiose-degrading enzyme activities were determined for whole cells, cell extracts and disrupted cells. Aryl-β-glucosidase activity was detected in whole cells and disrupted cells, suggesting that these activities are confined to the cells. The mutant produced 80 g l-1 of lactic acid from 100 g l-1 of cellobiose with 1.66 g l-1 h-1 productivity. Production of d-lactic acid from different cellulose samples was also studied. The cellulose samples at high concentration (10%) were hydrolyzed by cellulase enzyme preparation (10 FPU g-1 cellulose) derived from Penicillium janthinellum mutant EU1 generated in our own laboratory. We obtained a maximum 72% hydrolysis, yielding glucose and cellobiose as the main end products. Lactic acid was produced from these cellulose samples by simultaneous saccharification and fermentation (SSF) in a media containing a cellulase enzyme preparation derived from Penicillium janthinellum mutant EU1 and cellobiose utilizing Lactobacillus lactis mutant RM2-24. A maximum lactic acid concentration of 73 g l-1 was produced from a concentration of 100 g l-1 of bagasse-derived cellulose, the highest productivity and yield being 1.52 g l-1 h-1 and 0.73 g g-1, respectively. Considering that bagasse is a waste material available in abundance, we propose to use this biomass to produce cellulose and then sugars, which can be fermented to valuable products such as ethanol and lactic acid.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 10326-41-7